Clinical trial
Rubella Susceptibility in Multiparous Women
NCT00401505 · Unity Health Toronto, Other · Completed
Key facts
| NCT number | NCT00401505 |
|---|---|
| Title | Rubella Susceptibility in Multiparous Women |
| Official title | Rubella Susceptibility in Multiparous Women |
| Lead sponsor | Unity Health Toronto, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Rubella, Vaccine |
| Enrollment | 310 |
| Start date | Sep 1, 2006 |
| Primary completion | Sep 1, 2012 |
| Completion | Sep 1, 2012 |
| First posted | Nov 20, 2006 |
| Last update posted | Feb 22, 2019 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: